Grifols (GRFS) Income towards Parent Company (2010 - 2019)

Grifols (GRFS) posted Income towards Parent Company of $330.1 million for Q1 2020, down 55.46% quarter-over-quarter from $741.2 million in Q4 2019, and up 69.41% year-on-year from $194.8 million in Q2 2019.

Grifols (GRFS) Income towards Parent Company (2010 - 2019) Analysis & Trends

Grifols (GRFS) has reported Income towards Parent Company for 11 consecutive years, with $330.1 million the latest figure, recorded in Q1 2020.

  • Income towards Parent Company for Q1 2020 came in at $330.1 million, up 69.41% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.0 (changed 0.0% YoY), and the FY2025 annual result was $467.9 million, up 178.92% from the prior year.
  • Income towards Parent Company was $330.1 million for Q1 2020 at Grifols, down from $741.2 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $882.3 million in Q4 2017 and troughed at $136.4 million in Q2 2016.
  • Average Income towards Parent Company over 5 years is $358.1 million, with a median of $247.9 million recorded in 2017.
  • The widest YoY moves for Income towards Parent Company: up 486.37% in 2017, down 35.0% in 2017.
  • Over 5 years, Income towards Parent Company stood at $150.5 million in 2016, then surged by 486.37% to $882.3 million in 2017, then decreased by 9.06% to $802.4 million in 2018, then slipped by 7.63% to $741.2 million in 2019, then sank by 55.46% to $330.1 million in 2020.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $330.1 million in Q1 2020, $741.2 million in Q4 2019, and $194.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2019 741.18 Mn
Dec 31, 2018 802.38 Mn
Jun 30, 2018 380.68 Mn
Dec 31, 2017 882.31 Mn
Dec 31, 2016 150.47 Mn
Sep 30, 2016 453.28 Mn
Dec 31, 2015 143.08 Mn
Sep 30, 2015 155.84 Mn
Jun 30, 2015 147.00 Mn
Mar 31, 2015 145.17 Mn
Dec 31, 2014 -529.86 Mn
Sep 30, 2014 449.93 Mn
Jun 30, 2014 308.44 Mn
Mar 31, 2014 165.78 Mn
Dec 31, 2013 149.34 Mn
Sep 30, 2013 353.83 Mn
Jun 30, 2013 238.69 Mn
Mar 31, 2013 120.15 Mn
Dec 31, 2012 110.36 Mn
Sep 30, 2012 246.80 Mn